Market LIVE
Published markets; coverage varies by country
Product profile · United States

HEPARIN SODIUM

 ·  Patent Litigation & Settlement History ↓

IngredientHEPARIN SODIUM
Application typeNDA
Application017029
Product020
Dosage formINJECTABLE
RouteINJECTION
Strength10,000 UNITS/ML
Approval date2011-03-31
Marketing statusPrescription
Status event—
ApplicantFRESENIUS KABI USA
Product source

Current GenericRadar decision

Year2011
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeAPPROVAL_YEAR_FALLBACK
Anchor date2011-03-31
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

Available evidence does not establish a full-scope DS/DS-equivalent or full-coverage exclusivity anchor; approval-year DEEP_REVIEW is proposed. Direct Final-ANDA linkage may change the result.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
087107 / 001FINAL_APPROVAL_DATE_UNCONFIRMED · FINAL_APPROVAL_DATE_UNCONFIRMED——SOLOPAK MEDICAL PRODUCTS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
089522 / 001FINAL_APPROVAL · FINAL_APPROVED1987-05-04—HOSPIRA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
040095 / 001FINAL_APPROVAL · FINAL_APPROVED1996-07-26—HOSPIRA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090571 / 003FINAL_APPROVAL · FINAL_APPROVED2009-08-31—HOSPIRA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090808 / 003FINAL_APPROVAL · FINAL_APPROVED2010-06-30—SAGENT PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
201002 / 001FINAL_APPROVAL · FINAL_APPROVED2011-06-08—PLANO PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
203198 / 001FINAL_APPROVAL · FINAL_APPROVED2014-06-12—SHENZHEN TECHDOW PHARMACEUTICAL CO LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
203851 / 003FINAL_APPROVAL · FINAL_APPROVED2017-11-30—PHARMOBEDIENT CONSULTING LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211007 / 003FINAL_APPROVAL · FINAL_APPROVED2019-05-28—EMERGE BIOSCIENCE PTE LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212060 / 001FINAL_APPROVAL · FINAL_APPROVED2020-04-02—EMERGE BIOSCIENCE PTE LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
214839 / 001FINAL_APPROVAL · FINAL_APPROVED2020-12-29—BE PHARMACEUTICALS AGNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 10 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
089522 / 001HOSPIRA INCFINAL_APPROVAL · FINAL_APPROVED1987-05-04 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
040095 / 001HOSPIRA INCFINAL_APPROVAL · FINAL_APPROVED1996-07-26 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090571 / 003HOSPIRA INCFINAL_APPROVAL · FINAL_APPROVED2009-08-31 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090808 / 003SAGENT PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2010-06-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
201002 / 001PLANO PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2011-06-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
203198 / 001SHENZHEN TECHDOW PHARMACEUTICAL CO LTDFINAL_APPROVAL · FINAL_APPROVED2014-06-12 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
203851 / 003PHARMOBEDIENT CONSULTING LLCFINAL_APPROVAL · FINAL_APPROVED2017-11-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211007 / 003EMERGE BIOSCIENCE PTE LTDFINAL_APPROVAL · FINAL_APPROVED2019-05-28 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212060 / 001EMERGE BIOSCIENCE PTE LTDFINAL_APPROVAL · FINAL_APPROVED2020-04-02 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
214839 / 001BE PHARMACEUTICALS AGFINAL_APPROVAL · FINAL_APPROVED2020-12-29 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.